{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T23:01:42Z","timestamp":1781218902448,"version":"3.54.1"},"update-to":[{"DOI":"10.1002\/14651858.cd013160","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,5,18]],"date-time":"2019-05-18T00:00:00Z","timestamp":1558137600000}}],"reference-count":68,"publisher":"Wiley","issue":"5","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd013160.pub2","type":"journal-article","created":{"date-parts":[[2019,5,18]],"date-time":"2019-05-18T18:46:16Z","timestamp":1558205176000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Single-dose intravesical chemotherapy after nephroureterectomy for upper tract urothelial carcinoma"],"prefix":"10.1002","volume":"2019","author":[{"given":"Eu Chang","family":"Hwang","sequence":"first","affiliation":[{"name":"Chonnam National University Medical School, Chonnam National University Hwasun Hospital; Department of Urology; Hwasun Korea, South"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niranjan J","family":"Sathianathen","sequence":"additional","affiliation":[{"name":"University of Minnesota; Department of Urology; Minneapolis Minnesota USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Hung","family":"Jung","sequence":"additional","affiliation":[{"name":"Yonsei University Wonju College of Medicine; Department of Urology; 20 Ilsan-ro Wonju Gangwon Korea, South 26426"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myung Ha","family":"Kim","sequence":"additional","affiliation":[{"name":"Yonsei University Wonju College of Medicine; Yonsei Wonju Medical Library; Wonju Korea, South"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Dahm","sequence":"additional","affiliation":[{"name":"Minneapolis VA Health Care System; Urology Section; One Veterans Drive Mail Code 112D Minneapolis Minnesota USA 55417"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C","family":"Risk","sequence":"additional","affiliation":[{"name":"Minneapolis VA Health Care System; Urology Section; One Veterans Drive Mail Code 112D Minneapolis Minnesota USA 55417"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,5,18]]},"reference":[{"issue":"4","key":"10.1002\/14651858.CD013160.pub2-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"e270","DOI":"10.1016\/j.juro.2011.02.1599","article-title":"Prospective randomized phase II trial of single early intravesical instillation of (2'r)-4'-o-Tetrahydropyranyl-doxorubicin (THP) for prevention of bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma (UUT-UC)","volume":"185","author":"Ito","year":"2011","journal-title":"Journal of Urology"},{"issue":"11","key":"10.1002\/14651858.CD013160.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1200\/JCO.2012.45.2128","article-title":"Prospective randomized phase II trial of a single early intravesical instillation of pirarubicin (THP) in the prevention of bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma: the THP monotherapy study group trial","volume":"31","author":"Ito","year":"2013","journal-title":"Journal of Clinical Oncology"},{"issue":"11","key":"10.1002\/14651858.CD013160.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1093\/jjco\/hyt129","article-title":"Intravesical seeding of upper urinary tract urothelial carcinoma cells during nephroureterectomy: an exploratory analysis from the THPMG trial","volume":"43","author":"Ito","year":"2013","journal-title":"Japanese Journal of Clinical Oncology"},{"issue":"4","key":"10.1002\/14651858.CD013160.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.eururo.2011.05.064","article-title":"Prevention of bladder tumours after nephroureterectomy for primary upper urinary tract urothelial carcinoma: a prospective, multicentre, randomised clinical trial of a single postoperative intravesical dose of mitomycin C (the ODMIT-C Trial)","volume":"60","author":"O'Brien","year":"2011","journal-title":"European Urology"},{"issue":"5","key":"10.1002\/14651858.CD013160.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1046\/j.1442-2042.2001.00286.x","article-title":"Prophylactic intravesical instillation of mitomycin C and cytosine arabinoside for prevention of recurrent bladder tumors following surgery for upper urinary tract tumors: a prospective randomized study","volume":"8","author":"Sakamoto","year":"2001","journal-title":"International Journal of Urology"},{"key":"10.1002\/14651858.CD013160.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.conctc.2018.01.007","article-title":"Reduce bladder cancer recurrence in patients treated for upper urinary tract urothelial carcinoma: the REBACARE-trial","volume":"9","author":"Doeveren","year":"2018","journal-title":"Contemporary Clinical Trials Communications"},{"key":"10.1002\/14651858.CD013160.pub2-BIB0007|cit7","unstructured":"JPRN-UMIN000009682 Randomized control trial of a single postoperative intravesical instillation of THP for prevention of intravesical recurrence after nephroureterectomy apps.who.int\/trialsearch\/Trial2.aspx?TrialID=JPRN-UMIN000009682"},{"issue":"1","key":"10.1002\/14651858.CD013160.pub2-BIB0008|cit8","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1093\/jjco\/hyx158","article-title":"A phase III trial of a single early intravesical instillation of pirarubicin to prevent bladder recurrence after radical nephroureterectomy for upper tract urothelial carcinoma (JCOG1403, UTUC THP Phase III)","volume":"48","author":"Miyamoto","year":"2018","journal-title":"Japanese Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD013160.pub2-BIB0009|cit9","unstructured":"NCT02547350 Prophylactic intravesical chemotherapy to prevent bladder tumors after nephroureterectomy for primary upper urinary tract urothelial carcinomas clinicaltrials.gov\/ct2\/show\/record\/NCT02547350"},{"key":"10.1002\/14651858.CD013160.pub2-BIB0010|cit10","unstructured":"NCT02923557 Prophylactic intravesical chemotherapy to prevent bladder recurrence after nephroureterectomy for primary upper tract urothelial carcinoma patients clinicaltrials.gov\/ct2\/show\/record\/NCT02923557"},{"key":"10.1002\/14651858.CD013160.pub2-BIB0011|cit11","unstructured":"NCT03062059 The effectiveness and safety of intravesical gemcitabine instillation to prevent intravesical recurrence clinicaltrials.gov\/ct2\/show\/NCT03062059"},{"key":"10.1002\/14651858.CD013160.pub2-BIB0012|cit12","unstructured":"NCT03209206 The effectiveness and safety of intravesical docetaxel instillation for prevent bladder recurrence clinicaltrials.gov\/ct2\/show\/NCT03209206"},{"issue":"4","key":"10.1002\/14651858.CD013160.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"477","DOI":"10.6004\/jnccn.2013.0060","article-title":"Perioperative intravesical chemotherapy in non-muscle-invasive bladder cancer: a systematic review and meta-analysis","volume":"11","author":"Abern","year":"2013","journal-title":"Journal of the National Comprehensive Cancer Network"},{"issue":"4","key":"10.1002\/14651858.CD013160.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1200\/JCO.2008.20.8199","article-title":"Randomized phase III trial on gemcitabine versus mytomicin in recurrent superficial bladder cancer: evaluation of efficacy and tolerance","volume":"28","author":"Addeo","year":"2010","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD013160.pub2-BIB0015|cit15","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-40618-3","volume-title":"AJCC Cancer Staging Manual","author":"Amin","year":"2017"},{"issue":"2","key":"10.1002\/14651858.CD013160.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.urolonc.2009.06.003","article-title":"Bladder recurrence after surgery for upper urinary tract urothelial cell carcinoma: frequency, risk factors, and surveillance","volume":"29","author":"Az\u00e9mar","year":"2011","journal-title":"Urologic Oncology"},{"issue":"5","key":"10.1002\/14651858.CD013160.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.urology.2012.12.059","article-title":"Comparative analysis of oncologic outcomes of partial ureterectomy vs radical nephroureterectomy in upper tract urothelial carcinoma","volume":"81","author":"Bagrodia","year":"2013","journal-title":"Urology"},{"issue":"7","key":"10.1002\/14651858.CD013160.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"453","DOI":"10.4111\/kju.2014.55.7.453","article-title":"Predictors of intravesical recurrence after radical nephroureterectomy for upper urinary tract urothelial carcinoma: an inflammation-based prognostic score","volume":"55","author":"Cho","year":"2014","journal-title":"Korean Journal of Urology"},{"issue":"13","key":"10.1002\/14651858.CD013160.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/j.ejca.2008.05.008","article-title":"Quality, interpretation and presentation of European Organisation for Research and Treatment of Cancer quality of life questionnaire core 30 data in randomised controlled trials","volume":"44","author":"Cocks","year":"2008","journal-title":"European Journal of Cancer"},{"issue":"10","key":"10.1002\/14651858.CD013160.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1111\/j.1464-410X.2009.08838.x","article-title":"Environmental factors involved in carcinogenesis of urothelial cell carcinomas of the upper urinary tract","volume":"104","author":"Colin","year":"2009","journal-title":"BJU International"},{"key":"10.1002\/14651858.CD013160.pub2-BIB0021|cit21","unstructured":"Veritas Health Innovation Covidence 2017"},{"key":"10.1002\/14651858.CD013160.pub2-BIB0022|cit22","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0 ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/docs\/CTCAE_v5_Quick_Reference_8.5x11.pdf"},{"key":"10.1002\/14651858.CD013160.pub2-BIB0023|cit23","unstructured":"Deeks JJ Higgins JPT Altman DG (editors) Cochrane Statistical Methods Group Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.2.0 (updated June 2017), Cochrane, 2017 Available from www.training.cochrane.org\/handbook"},{"issue":"12","key":"10.1002\/14651858.CD013160.pub2-BIB0024|cit24","first-page":"4734","article-title":"Prognostic value and efficacy valuation of postoperative intravesical instillation in primary urothelial carcinomas of upper urinary tract","volume":"7","author":"Deng","year":"2014","journal-title":"International Journal of Clinical and Experimental Medicine"},{"key":"10.1002\/14651858.CD013160.pub2-BIB0025|cit25","unstructured":"Clarivate Analytics EndNote 2016"},{"issue":"3","key":"10.1002\/14651858.CD013160.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1159\/000350508","article-title":"Prophylactic intravesical chemotherapy to prevent bladder tumors after nephroureterectomy for primary upper urinary tract urothelial carcinomas: a systematic review and meta-analysis","volume":"91","author":"Fang","year":"2013","journal-title":"Urologia Internationalis"},{"issue":"4","key":"10.1002\/14651858.CD013160.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.juro.2012.05.079","article-title":"Urothelial carcinoma of the bladder and the upper tract: disparate twins","volume":"189","author":"Green","year":"2013","journal-title":"Journal of Urology"},{"issue":"2","key":"10.1002\/14651858.CD013160.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ucl.2013.01.005","article-title":"Side effects of perioperative intravesical treatment and treatment strategies for these side effects","volume":"40","author":"Griffin","year":"2013","journal-title":"Urologic Clinics of North America"},{"issue":"5","key":"10.1002\/14651858.CD013160.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/ijcp.12075","article-title":"Current perspectives in bladder cancer management","volume":"67","author":"Griffiths","year":"2013","journal-title":"International Journal of Clinical Practice"},{"issue":"7651","key":"10.1002\/14651858.CD013160.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1136\/bmj.39490.551019.BE","article-title":"What is \"quality of evidence\" and why is it important to clinicians?","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"12","key":"10.1002\/14651858.CD013160.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.jclinepi.2011.01.012","article-title":"GRADE guidelines 6. Rating the quality of evidence - imprecision","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD013160.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction - GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"8879","key":"10.1002\/14651858.CD013160.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/0140-6736(93)92066-3","article-title":"Metachronous multifocal development of urothelial cancers by intraluminal seeding","volume":"342","author":"Habuchi","year":"1993","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD013160.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S0090-4295(98)00295-7","article-title":"Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients","volume":"52","author":"Hall","year":"1998","journal-title":"Urology"},{"issue":"11","key":"10.1002\/14651858.CD013160.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Statistics in Medicine"},{"issue":"7414","key":"10.1002\/14651858.CD013160.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD013160.pub2-BIB0037|cit37","unstructured":"Higgins JPT Deeks JJ Altman DG editor(s) Cochrane Statistical Methods Group Chapter 16: Special topics in statistics. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD013160.pub2-BIB0038|cit38","unstructured":"Higgins JPT Churchill R Chandler J Cumpston MS (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.2.0 (updated June 2017), Cochrane, 2017 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD013160.pub2-BIB0039|cit39","unstructured":"Higgins JPT Altman DG Sterne JAC (editors) Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.2.0 (updated June 2017), Cochrane, 2017 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD013160.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2288-5-13","article-title":"Estimating the mean and variance from the median, range, and the size of a sample","volume":"5","author":"Hozo","year":"2005","journal-title":"BMC Medical Research Methodology"},{"key":"10.1002\/14651858.CD013160.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/1477-7525-11-109","article-title":"Patient-reported outcomes in meta-analyses - Part 1: assessing risk of bias and combining outcomes","volume":"11","author":"Johnston","year":"2013","journal-title":"Health and Quality of Life Outcomes"},{"issue":"18","key":"10.1002\/14651858.CD013160.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"6512","DOI":"10.1158\/1078-0432.CCR-05-0891","article-title":"Molecular evidence supporting field effect in urothelial carcinogenesis","volume":"11","author":"Jones","year":"2005","journal-title":"Clinical Cancer Research"},{"key":"10.1002\/14651858.CD013160.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12885-015-1161-9","article-title":"Are urothelial carcinomas of the upper urinary tract a distinct entity from urothelial carcinomas of the urinary bladder? Behavior of urothelial carcinoma after radical surgery with respect to anatomical location: a case control study","volume":"15","author":"Kim","year":"2015","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1002\/14651858.CD013160.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"e1055","DOI":"10.1016\/j.clgc.2017.07.009","article-title":"Predictors for intravesical recurrence following radical nephroureterectomy for upper tract urothelial carcinoma: a national multicenter analysis","volume":"15","author":"Lee","year":"2017","journal-title":"Clinical Genitourinary Cancer"},{"issue":"7","key":"10.1002\/14651858.CD013160.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"e1000100","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"PLOS Medicine"},{"issue":"3","key":"10.1002\/14651858.CD013160.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"113.e1","DOI":"10.1016\/j.urolonc.2016.10.016","article-title":"Intravesical chemotherapy use after radical nephroureterectomy: a national survey of urologic oncologists","volume":"35","author":"Lu","year":"2017","journal-title":"Urologic Oncology"},{"issue":"3","key":"10.1002\/14651858.CD013160.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00345-016-1826-2","article-title":"Prognostic factors and predictive tools for upper tract urothelial carcinoma: a systematic review","volume":"35","author":"Mbeutcha","year":"2017","journal-title":"World Journal of Urology"},{"key":"10.1002\/14651858.CD013160.pub2-BIB0048|cit48","unstructured":"Bladder Cancer, NCCN Clinical Practice Guidelines in Oncology https:\/\/www.nccn.org\/professionals\/physician_gls\/default.aspx#site"},{"issue":"8","key":"10.1002\/14651858.CD013160.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1002\/cncr.22970","article-title":"Independent predictors of cancer-specific survival in transitional cell carcinoma of the upper urinary tract: multi-institutional dataset from 3 European centers","volume":"110","author":"Novara","year":"2007","journal-title":"Cancer"},{"issue":"1","key":"10.1002\/14651858.CD013160.pub2-BIB0050|cit50","first-page":"3","article-title":"Evidenced-based clinical practice guideline for upper tract urothelial carcinoma (summary)","volume":"22","author":"Oya","year":"2015","journal-title":"International Journal of Uology"},{"issue":"24","key":"10.1002\/14651858.CD013160.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1002\/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8","article-title":"Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints","volume":"17","author":"Parmar","year":"1998","journal-title":"Statistics in Medicine"},{"issue":"3","key":"10.1002\/14651858.CD013160.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.eururo.2013.06.009","article-title":"Immediate post-transurethral resection of bladder tumor intravesical chemotherapy prevents non-muscle-invasive bladder cancer recurrences: an updated meta-analysis on 2548 patients and quality-of-evidence review","volume":"64","author":"Perlis","year":"2013","journal-title":"European Urology"},{"key":"10.1002\/14651858.CD013160.pub2-BIB0053|cit53","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014"},{"issue":"1","key":"10.1002\/14651858.CD013160.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.eururo.2017.07.036","article-title":"European Association of Urology Guidelines on upper urinary tract urothelial carcinoma: 2017 update","volume":"73","author":"Roupr\u00eat","year":"2018","journal-title":"European Urology"},{"issue":"1","key":"10.1002\/14651858.CD013160.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/jrsm.1078","article-title":"Non-randomized studies as a source of complementary, sequential or replacement evidence for randomized controlled trials in systematic reviews on the effects of interventions","volume":"4","author":"Sch\u00fcnemann","year":"2013","journal-title":"Research Synthesis Methods"},{"key":"10.1002\/14651858.CD013160.pub2-BIB0056|cit56","unstructured":"Sch\u00fcnemann HJ Oxman AD Higgins JPT Vist GE Glasziou P Akl E Cochrane GRADEing Methods Group and the Cochrane Statistical Methods Group Chapter 11: Completing \u2018Summary of findings\u2019 tables and grading the confidence in or quality of the evidence. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.2.0 (updated June 2017). Cochrane, 2017 Available from www.training.cochrane.org\/handbook"},{"issue":"1","key":"10.1002\/14651858.CD013160.pub2-BIB0057|cit57","first-page":"9","article-title":"Cancer statistics, 2014","volume":"64","author":"Siegel","year":"2014","journal-title":"CA"},{"issue":"2","key":"10.1002\/14651858.CD013160.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.eururo.2014.01.006","article-title":"The economics of bladder cancer: costs and considerations of caring for this disease","volume":"66","author":"Svatek","year":"2014","journal-title":"European Urology"},{"issue":"6 Pt 1","key":"10.1002\/14651858.CD013160.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1097\/01.ju.0000125486.92260.b2","article-title":"A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials","volume":"171","author":"Sylvester","year":"2004","journal-title":"Journal of Urology"},{"issue":"3","key":"10.1002\/14651858.CD013160.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","article-title":"Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials","volume":"49","author":"Sylvester","year":"2006","journal-title":"European Urology"},{"issue":"2","key":"10.1002\/14651858.CD013160.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.eururo.2015.05.050","article-title":"Systematic review and individual patient data meta-analysis of randomized trials comparing a single immediate instillation of chemotherapy after transurethral resection with transurethral resection alone in patients with stage pTa-pT1 urothelial carcinoma of the bladder: which patients benefit from the instillation?","volume":"69","author":"Sylvester","year":"2016","journal-title":"European Urology"},{"key":"10.1002\/14651858.CD013160.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1745-6215-8-16","article-title":"Practical methods for incorporating summary time-to-event data into meta-analysis","volume":"8","author":"Tierney","year":"2007","journal-title":"Trials"},{"issue":"6","key":"10.1002\/14651858.CD013160.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1517\/14656561003657145","article-title":"Intravesical therapy for bladder cancer","volume":"11","author":"Williams","year":"2010","journal-title":"Expert Opinion on Pharmacotherapy"},{"issue":"5","key":"10.1002\/14651858.CD013160.pub2-BIB0064|cit64","first-page":"1229","article-title":"Prophylactic intravesical chemotherapy decreases bladder tumor recurrence after nephroureterectomy for primary upper tract urothelial carcinoma: a systematic review and meta-analysis","volume":"20","author":"Wu","year":"2015","journal-title":"Journal of Balkan Union of Oncology"},{"issue":"4","key":"10.1002\/14651858.CD013160.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.eururo.2013.07.017","article-title":"Words of wisdom: re: Prospective randomized phase II trial of a single early intravesical instillation of pirarubicin (THP) in the prevention of bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma: the THP Monotherapy Study Group trial","volume":"64","author":"Xylinas","year":"2013","journal-title":"European Urology"},{"issue":"3","key":"10.1002\/14651858.CD013160.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.eururo.2013.09.003","article-title":"Prediction of intravesical recurrence after radical nephroureterectomy: development of a clinical decision-making tool","volume":"65","author":"Xylinas","year":"2014","journal-title":"European Urology"},{"issue":"4","key":"10.1002\/14651858.CD013160.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1179\/1973947815Y.0000000034","article-title":"The effect of intravesical chemotherapy in the prevention of intravesical recurrence after nephroureterectomy for upper tract urothelial carcinoma: a meta-analysis","volume":"27","author":"Yuan","year":"2015","journal-title":"Journal of Chemotherapy"},{"issue":"10","key":"10.1002\/14651858.CD013160.pub2-BIB0068|cit68","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013160","article-title":"Single-dose intravesical chemotherapy after nephroureterectomy for upper tract urothelial carcinoma","author":"Hwang","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD013160.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,26]],"date-time":"2023-12-26T03:33:02Z","timestamp":1703561582000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD013160.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Urology Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,5,18]]},"references-count":68,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2019,5]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd013160.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,18]]}}}